Xspray Pharma Targets Break-Even in 7-12 Months

Xspray Pharma, a Swedish drug developer using amorphous technology, states it can reach profitability within 7-12 months. This is a company-specific operational milestone, not a macro signal. The claim is based on management guidance and lacks independent verification.